Back
bluebird bio Quote, Financials, Valuation and Earnings
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
BLUE
bluebird bio
Last Price:
0.50
Seasonality Move:
-1.92%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerbluebird bio Price Quote
$0.50
+0.01 (+1.03%)
(Updated: September 19, 2024 at 1:30 PM ET)
bluebird bio Key Stats
Sell
8
bluebird bio (BLUE)
is a Sell
Day range:
$0.48 - $0.53
52-week range:
$0.48 - $5.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.43
P/B ratio:
0.73%
Volume:
7.6M
Avg. volume:
9.4M
1-year change:
-84.49%
Market cap:
$96M
Revenue:
$29.5M
EPS:
$-2.47
How Much Does bluebird bio Make?
-
How Much Are bluebird bio's Sales Annually?
BLUE Revenues are $29.5M -
How Much Profit Does bluebird bio's Make A Year?
BLUE net income is -$211.9M
Is bluebird bio Growing As A Company?
-
What Is bluebird bio's Growth Rate Quarterly?
Quarterly YoY revenue growth is 6.8% -
What Is bluebird bio's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
bluebird bio Stock Price Performance
-
Did bluebird bio Stock Go Up Last Month?
bluebird bio share price went down by -30.21% last month -
Did BLUE's Share Price Rise Over The Last Year?
BLUE share price fell by -84.49% over the past 1 year
What Is bluebird bio 52-Week High & Low?
-
What Is bluebird bio’s 52-Week High Share Price?
bluebird bio has traded as high as $5.53 over the past 52 weeks -
What Is bluebird bio’s 52-Week Low Share Price?
bluebird bio has traded as low as $0.48 over the past 52 weeks
bluebird bio Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy bluebird bio?
-
How Much Debt Does bluebird bio Have?
Total long term debt quarterly is $69M -
How Much Cash Does bluebird bio Have?
Cash and short term investments quarterly total is $212M -
What Is bluebird bio’s Book Value Per Share?
Book value per share is 0.68
Is bluebird bio Cash Flow Positive?
-
What Is BLUE Cash Flow From Operations?
Cash flow from operations (TTM) is -$238.4M -
What Is bluebird bio’s Cash Flow From Financing?
Cash flow from financing (TTM) is $145.7M -
What Is bluebird bio’s Cash Flow From Investing?
Cash flow from investing (TTM) is $72.2M
bluebird bio Return On Invested Capital
-
Is Management Doing A Good Job?
BLUE return on invested capital is -120.14% -
What Is bluebird bio Return On Assets?
ROA measures how assets are converting to revenues and is -47.04% -
What Is BLUE Return On Equity?
ROE is a measure of profitability and is -127.09%
bluebird bio Earnings Date & Stock Price
-
What Is bluebird bio's Stock Price Today?
A single share of BLUE can be purchased today for 0.49 -
What Is bluebird bio’s Stock Symbol?
bluebird bio trades on the nasdaq under the ticker symbol: BLUE -
When Is bluebird bio’s Next Earnings Date?
The next quarterly earnings date for bluebird bio is scheduled on November 7, 2024 -
When Is BLUE's next ex-dividend date?
bluebird bio's next ex-dividend date is September 19, 2024 -
How To Buy bluebird bio Stock?
You can buy bluebird bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
bluebird bio Competitors
-
Who Are bluebird bio's Competitors?
Below is a list of companies who compete with bluebird bio or are related in some way:
bluebird bio Dividend Yield
-
What Is BLUE Dividend Yield?
bluebird bio’s dividend yield currently is 0% -
What Is bluebird bio’s Payout Ratio?
bluebird bio’s payout ratio is 0% -
When Did bluebird bio Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is bluebird bio’s Dividend Per Share?
bluebird bio pays a dividend of $0.00 per share
bluebird bio Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 680.05% | -30.7% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 6 |
| Sell Recommendations: | 1 |
| Price Target: | 2.88 |
| Upside from Last Price: | 481.43% |